Shintaro Ogawa, PhD
- 2Articles
- 13.4KReads1
- 2014–2017Active
- 12Collaborators
- 209Citations2
About
Shintaro Ogawa, PhD, has published research on major depressive disorder (MDD), focusing on biochemical markers such as cerebrospinal fluid monoamine metabolite levels and plasma l-tryptophan concentrations. Contributions include original data and meta-analyses examining these neurochemical aspects in relation to clinical variables. Ogawa’s work, published between 2014 and 2017 in Psychiatrist.com journals, often involved collaboration with colleagues including Hiroshi Kunugi and Kotaro Hattori.
Publications
1 Read counts for articles published before 2020 may include some non-human traffic.
2 Citation counts provided by Crossref.
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
